Integrated Core Strategies (US) LLC 13D and 13G filings for Milestone Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-29 4:30 pm Purchase |
2024-09-30 | 13G | Milestone Pharmaceuticals Inc. MIST |
Integrated Core Strategies (US) LLC | 2,778,525 5.200% |
1,047,636 (+60.53%) |
Filing |
| 2024-01-29 4:42 pm Sale |
2023-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
Integrated Core Strategies (US) LLC | 1,730,889 5.200% |
-464,140 (-21.15%) |
Filing |
| 2023-01-18 4:40 pm Purchase |
2022-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
Integrated Core Strategies (US) LLC | 2,195,029 6.400% |
290,732 (+15.27%) |
Filing |
| 2022-10-31 4:40 pm Purchase |
2022-10-25 | 13G | Milestone Pharmaceuticals Inc. MIST |
Integrated Core Strategies (US) LLC | 1,904,297 6.300% |
1,904,297 (New Position) |
Filing |